This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Small-Cap Winners & Losers

The broad market took small-cap stocks on a wild ride Thursday, but among the solid winners was WSI Industries (WSCI - Get Report).

The Monticello, Minn., metal-machining company soared 22.2% to $5.74 after bumping up its fiscal third-quarter profit by 2 cents a share from last year to 8 cents, or $229,000, while revenue surged 24.3% to $5.2 million.

Lindsay (LNN - Get Report), an irrigation-systems maker, also issued positive earnings for the May quarter. The Omaha, Neb., company earned 62 cents a share, up 12.7% from last year, on 24.2% higher operating revenue at $93.1 million. Shares jumped 12.9%, or $5.08, to $44.33.

California's Advanced Cell Technology (ACTC) had a quick rise after announcing it successfully produced a human embryonic stem cell without destroying an embryo in the process. CEO William Caldwell said this development addresses the concerns of President Bush who, on Wednesday, again vetoed a bill to allow for federal funding of embryonic stem-cell research. ACT shares were up 9.9% to 73 cents in heavy trading.

Intevac (IVAC - Get Report), of Santa Clara, Calif., and Atlanta's Manhattan Associates (MANH - Get Report) both supported the Russell 2000 and the S&P SmallCap 600 indices, respectively up 0.2% and 0.1% lately, after getting a communal lift on positive analyst research.

Intevac, which makes disk-sputtering equipment for hard-disk drives, gained 2.5% to $20.05 after American Technology Research stamped on a buy rating. Analyst Bill Ong cited Intevac's development of a new plasma etch tool for the semiconductor industry, which he says could allow it to diversify away from the "ultra-competitive" hard-disk-drive market.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ACTC $6.24 -1.58%
ESE $38.06 0.00%
IVAC $4.75 0.00%
LNN $70.43 0.00%
MANH $58.85 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs